[Federal Register Volume 90, Number 228 (Monday, December 1, 2025)]
[Notices]
[Page 55136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-21600]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Muscular Dystrophy
Coordinating Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The meeting can be viewed on the NIH
Videocasting website, https://videocast.nih.gov/. Registration is not
required.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Date: December 22, 2025.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: The purpose of this meeting is to bring together
committee members, representing government agencies, patient
advocacy groups and people with lived experience to discuss topics
of interest to the muscular dystrophy communities. The agenda for
this meeting features panel discussions inviting industry leaders to
comment on priorities for the Action Plan, the MDCC's ten-year
strategic plan for research and other strategies to improve the
lives of people living with muscular dystrophies. The agenda for
this meeting is available on the MDCC website: https://www.mdcc.nih.gov/.
Address: National Institutes of Health, Neuroscience Center,
6001 Executive Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Glen Nuckolls, Ph.D., Program Director, National
Institute of Neurological Disorders and Stroke (NINDS), NIH NSC
Building, 6001 Executive Blvd. Bethesda, MD 20892, 301-496-5876,
[email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Dated: November 25, 2025,
Rosalind M. Niamke,
Program Analyst,Office of Federal Advisory Committee Policy.
[FR Doc. 2025-21600 Filed 11-28-25; 8:45 am]
BILLING CODE 4140-01-P